Laura Sutcliffe

Stock Analyst at UBS

(1.74)
# 1199
Out of 5,329 analysts
8
Total ratings
80.00%
Success rate
17.73%
Average return
6 Stocks
Name Action PT Current % Upside Ratings Updated
RMD ResMed
Maintains: Buy
290 285
236.43 20.54% 1 Apr 24, 2025
TLX Telix Pharmaceutical...
Maintains: Strong Buy
21 22
17.89 22.97% 2 Jan 27, 2025
UCBJY UCB
Upgrades: Buy
n/a
n/a n/a 1 Aug 23, 2021
ARGX argenx
Initiates Coverage On: Buy
390
638.88 -38.96% 1 Jun 18, 2021
GNHAF Vifor Pharma AG
Upgrades: Neutral
n/a
n/a n/a 1 Mar 1, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Dec 20, 2019